Silence to collaborate on oncology drug development

Silence Therapeutics Plc has announced plans to collaborate with a privately-owned company in the Netherlands, InteRNA Technologies BV, to develop microRNA therapeutics for the treatment of cancer. Financial details were not disclosed.